Status:
COMPLETED
Minimizing Pain During Office Intradetrussor Botox Injection
Lead Sponsor:
Boston Urogynecology Associates
Conditions:
Overactive Bladder
Overactive Detrusor
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This will be a prospective double-blinded randomized controlled trial comparing two pre-treatment protocols for patients undergoing intradetrussor botox injections to determine if a buffered lidocaine...
Detailed Description
Lidocaine is a commonly used amide-type local anesthetic. Lidocaine exists as both a quaternary water soluble structure, and a tertiary lipid-soluble structure. Only the tertiary lipid-soluble structu...
Eligibility Criteria
Inclusion
- Female patient
- Primary diagnosis of overactive bladder
- Failed first and second line therapy for overactive bladder
- Planning to undergo bladder botox injections
Exclusion
- Neurogenic bladder
- Urinary retention
Key Trial Info
Start Date :
August 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04270526
Start Date
August 15 2020
End Date
June 30 2023
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Urogynecology Associates
Cambridge, Massachusetts, United States, 02138